Terns Pharmaceuticals Inc... (TERN)

2.94

0.02 (0.68%)

At close: Apr 28, 2025, 3:59 PM

2.87

-2.55%

After-hours: Apr 28, 2025, 04:34 PM EDT

Terns Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	161.44M	79.93M	143.24M	47.7M	74.85M	12.33M	82.52M
Short-Term Investments	196.72M	183.51M	139.88M	118.28M	n/a	7.32M	4.36M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	350K	56K	37K	94K	246K	719K	335K
Receivables	n/a	n/a	n/a	n/a	12.72M	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	2.97M	n/a	n/a
Other Current Assets	3.94M	3.99M	2.07M	948K	2.14M	461K	162K
Total Current Assets	362.11M	267.43M	285.19M	166.93M	90.87M	22.22M	88.48M
Property-Plant & Equipment	1.47M	1.03M	1.8M	1.05M	1.18M	961K	261K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.82M	1.08M	1.84M	1.14M	1.42M	1.68M	596K
Total Assets	363.93M	268.52M	287.03M	168.07M	92.29M	23.9M	89.07M
Account Payables	2.15M	2.52M	1.65M	2.13M	935K	1.64M	914K
Deferred Revenue	n/a	n/a	n/a	n/a	836K	n/a	n/a
Short-Term Debt	428K	n/a	661K	n/a	12.88M	n/a	n/a
Other Current Liabilities	8.37M	5.96M	3.37M	358K	6.68M	117K	127K
Total Current Liabilities	15.65M	11.94M	8.47M	6.82M	22.82M	4.95M	2.38M
Long-Term Debt	919K	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	1.49M	1.21M	1.07M	947K	877K	14.4M	14.32M
Total Long-Term Liabilities	2.41M	1.21M	1.61M	947K	877K	14.75M	14.47M
Total Liabilities	18.06M	13.15M	10.08M	7.77M	23.7M	19.7M	16.84M
Total Debt	1.35M	603K	1.21M	n/a	12.88M	n/a	n/a
Common Stock	9K	6K	5K	3K	n/a	n/a	n/a
Retained Earnings	-421.48M	-332.63M	-242.42M	-182.07M	-131.91M	-91.86M	-23.25M
Comprehensive Income	-279K	-19K	-822K	-338K	-124K	-106K	59K
Shareholders Equity	345.87M	255.37M	276.94M	160.3M	68.59M	4.21M	72.23M
Total Investments	196.72M	183.51M	139.88M	118.28M	n/a	7.32M	4.36M